Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?
Stockhead TV
VIDEO: 90 Seconds With… Ralph Highnam, Volpara Health Technologies
Director Trades
Directors Trades: These directos are selling millions to make way for the instos
Private-i
Medtech company Volpara tapped a global network of private investors for its $55m capital raise
Health & Biotech
Biotech: Paradigm might be able to fix your bung Ross River virus joints with an injection
Experts
Money Talks: 80-20 Investments’ Angie Ellis shares her hot software stock tips
Health & Biotech
Zoono is a $24m company. It just sold $33m worth of product
Health & Biotech
The total market cap of small cap ASX medtechs grew 57pc in the past year
Stockhead TV
VIDEO: 90 Seconds With… Ralph Highnam, Volpara Health Technologies
Health & Biotech
There’s a bit of promise for health small caps in the federal Budget – but there’s also a big ‘if’
Health & Biotech
The FDA just gave breast screener Volpara a major leg-up in the US
Tech
Stop Robot Abuse: AI businesses have to start thinking about ethics
Health & Biotech
Two medical device smallcaps are up, one is down after a soft quarterly
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
News
Lunchtime ASX small cap wrap: who held on amid the carnage
Health & Biotech
Expert view: why it’s a critical time for investment in ASX small cap health stocks
Health & Biotech